Nasdaq Ys News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq ys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Ys Today - Breaking & Trending Today
YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) shares were down 3.4% during mid-day trading on Friday . The company traded as low as $0.39 and last traded at $0.40. Approximately 99,903 shares were traded during trading, a decline of 41% from the average daily volume of 168,291 shares. The stock had previously closed […] ....
Noble Financial assumed coverage on shares of YS Biopharma (NASDAQ:YS – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage issued an outperform rating and a $5.25 price target on the stock. YS Biopharma Stock Down 1.4 % NASDAQ YS opened at $0.65 on Monday. The company has a current […] ....
YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 98,300 shares, a drop of 86.1% from the August 31st total of 706,300 shares. Based on an average trading volume of 922,700 shares, the days-to-cover […] ....
Hhlr Advisors LTD. purchased a new position in YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 751,790 shares of the company’s stock, valued at approximately $1,203,000. Hhlr Advisors LTD. owned approximately 2.92% of YS Biopharma at the […] ....
Valliance Asset Management Ltd bought a new position in shares of YS Biopharma Co., Ltd. (NASDAQ:YS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,607,175 shares of the company’s stock, valued at approximately $2,571,000. YS Biopharma comprises approximately 4.6% of Valliance […] ....